Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Laparoscopic Nissen vs Toupet fundoplication for hiatal hernia with reflux

Official title: Laparoscopic Nissen Versus Toupet Fundoplication for Gastroesophageal Reflux Management in Patients With Hiatal Hernia: A Patient- and Assessor-Blinded Randomized Controlled Trial

Run by Sofia Med Hospital · NCT07718828 · Data updated 2026-11-12

This trial tests whether Nissen or Toupet fundoplication, performed laparoscopically, provides better outcomes for adults with hiatal hernia and reflux disease.

More Hiatal Hernia trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment200 (estimated)
SponsorSofia Med Hospital
Academic / other
Locations1 site (Sofia, Sofia-Grad)
StatusRecruiting
StartedMay 29, 2023
Main results expectedJuly 30, 2026
Study endsJanuary 31, 2027
Registry record updatedJuly 22, 2026
Trial IDNCT07718828 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 90 with a primary hiatal hernia and gastroesophageal reflux symptoms scheduled for elective laparoscopic repair with fundoplication.

Probably not a fit

Patients outside the age range, with recurrent hiatal hernia, without reflux symptoms, not suitable for general anesthesia, or not opting for laparoscopic surgery may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two laparoscopic anti-reflux surgeries—Nissen and Toupet fundoplication—in adults with primary hiatal hernia and gastroesophageal reflux symptoms. Participants are assigned to one of the two surgical approaches and outcomes such as postoperative pain, quality of life, hospital stay, reflux recurrence, gas-bloat symptoms, operative times, and complications are tracked. The study uses standard elective laparoscopic hiatal hernia repair with fundoplication and follows patients through postoperative recovery to assess relative benefits and risks. No details are provided about long-term follow-up beyond the immediate postoperative and short-term outcomes. The trial is conducted at Sofia Med Hospital in Sofia, Bulgaria, with a single lead sponsor and no listed collaborators.

Why it matters

Potential benefit: If successful, the trial could clarify which fundoplication technique yields better symptom control and recovery for patients with hiatal hernia and reflux.

How similar studies have gone: Similar randomized comparisons exist in the literature, but evidence remains mixed; this trial adds direct comparative data in a contemporary laparoscopic setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 to 90 years
* Patients diagnosed with primary hiatal hernia by fibrogastroscopy and/or barium swallow examination
* Patients with symptoms of gastroesophageal reflux disease
* Patients scheduled for elective laparoscopic hiatal hernia repair with fundoplication
* Patients able to provide informed consent

Exclusion Criteria:

Patients younger than 18 years or older than 90 years Patients with recurrent hiatal hernia Patients who are not suitable for general anesthesia Patients who prefer a surgical approach other than laparoscopic surgery Patients who are unable or unwilling to provide informed consent

Where it's running

  • UMHAT Sofiamed
    Sofia, Sofia-Grad, Bulgaria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.